EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting

Guoshuai Xu iD, Qinghong Zhang, Renjia Cheng, Jun Qu, Wenqiang Li iD

Autophagy · 03.04.2025 · 21 (4) · 693-718

DOI: 10.1080/15548627.2025.2452149 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Autophagy, online erschienen am 26.01.2025. Verfasst von Guoshuai Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Aerospace Center Hospital, Beijing, China. Hauptthemen laut MEDLINE: Pinocytosis, Neoplasms, Nutrients. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 299 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aerospace Medical Health Technology Group Co., LTD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macropinocytosis is a nonselective form of endocytosis that allows cancer cells to largely take up the extracellular fluid and its contents, including nutrients, growth factors, etc. We first elaborate meticulously on the process of macropinocytosis. Only by thoroughly understanding this entire process can we devise targeted strategies against it. We then focus on the central role of the MTOR (mechanistic target of rapamycin kinase) complex 1 (MTORC1) in regulating macropinocytosis, highlighting its significance as a key signaling hub where various pathways converge to control nutrient uptake and metabolic processes. The article covers a comprehensive analysis of the literature on the molecular mechanisms governing macropinocytosis, including the initiation, maturation, and recycling of macropinosomes, with an emphasis on how these processes are hijacked by cancer cells to sustain their growth. Key discussions include the potential therapeutic strategies targeting macropinocytosis, such as enhancing drug delivery via this pathway, inhibiting macropinocytosis to starve cancer cells, blocking the degradation and recycling of macropinosomes, and inducing methuosis - a form of cell death triggered by excessive macropinocytosis. Targeting macropinocytosis represents a novel and innovative approach that could significantly advance the treatment of cancers that rely on this pathway for survival. Through continuous research and innovation, we look forward to developing more effective and safer anti-cancer therapies that will bring new hope to patients.Abbreviation: AMPK: AMP-activated protein kinase; ASOs: antisense oligonucleotides; CAD: carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase; DC: dendritic cell; EGF: epidermal growth factor; EGFR: epidermal growth factor receptor; ERBB2: erb-b2 receptor tyrosine kinase 2; ESCRT: endosomal sorting complex required for transport; GAP: GTPase-activating protein; GEF: guanine nucleotide exchange factor; GRB2: growth factor receptor bound protein 2; LPP: lipopolyplex; MTOR: mechanistic target of rapamycin kinase; MTORC1: mechanistic target of rapamycin kinase complex 1; MTORC2: mechanistic target of rapamycin kinase complex 2; NSCLC: non-small cell lung cancer; PADC: pancreatic ductal adenocarcinoma; PDPK1: 3-phosphoinositide dependent protein kinase 1; PI3K: phosphoinositide 3-kinase; PIK3C3: phosphatidylinositol 3-kinase catalytic subunit type 3; PtdIns(3,4,5)P3: phosphatidylinositol-(3,4,5)-trisphosphate; PtdIns(4,5)P2: phosphatidylinositol-(4,5)-bisphosphate; PTT: photothermal therapies; RAC1: Rac family small GTPase 1; RPS6: ribosomal protein S6; RPS6KB1: ribosomal protein S6 kinase B1; RTKs: receptor tyrosine kinases; SREBF: sterol regulatory element binding transcription factor; TFEB: transcription factor EB; TNBC: triple-negative breast cancer; TSC2: TSC complex subunit 2; ULK1: unc-51 like autophagy activating kinase 1; UPS: ubiquitin-proteasome system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PinocytosisNeoplasmsNutrientsHumansAnimalsCell SurvivalSignal TransductionMechanistic Target of Rapamycin Complex 1Metabolic Reprogramming

Stichwörter der Autor:innen

Anti-cancer therapiesMTORC1MTORC2macropinocytosismetabolic reprogrammingmethuosis

Substanzen

NutrientsMechanistic Target of Rapamycin Complex 1

Autor:innen und Institutionen

  • Department of General Surgery, Aerospace Center Hospital, Beijing, China.
  • Emergency Department, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Intensive Care Medicine, The General Hospital of the Northern Theater Command of the People's Liberation Army of China, Shenyang, Liaoning, China.

ORCID-Profile: Guoshuai Xu, Wenqiang Li

Förderung

  • Aerospace Medical Health Technology Group Co., LTD

Zitieren

APA

Xu, G., Zhang, Q., Cheng, R., Qu, J., & Li, W. (2025). Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting. Autophagy, 21(4), 693-718. https://doi.org/10.1080/15548627.2025.2452149

Vancouver

Xu G, Zhang Q, Cheng R, Qu J, Li W. Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting. Autophagy. 2025;21(4):693-718. doi:10.1080/15548627.2025.2452149

BibTeX
@article{Xu2025,
  author = {Xu, Guoshuai and Zhang, Qinghong and Cheng, Renjia and Qu, Jun and Li, Wenqiang},
  title = {Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting},
  journal = {Autophagy},
  year = {2025},
  volume = {21},
  number = {4},
  pages = {693--718},
  doi = {10.1080/15548627.2025.2452149}
}
Kostenlos starten →